Pacritinib 100 mg C78837 Pill - gray & red capsule/oblong, 22mm
Generic Name: pacritinib
Pill with imprint Pacritinib 100 mg C78837 is Gray & Red, Capsule/Oblong and has been identified as Vonjo 100 mg. It is supplied by CTI BioPharma Corp.
Vonjo is used in the treatment of Myelofibrosis and belongs to the drug class multikinase inhibitors. Vonjo 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pacritinib 100 mg C78837
Vonjo
- Generic Name
- pacritinib
- Imprint
- Pacritinib 100 mg C78837
- Strength
- 100 mg
- Color
- Gray & Red
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- CTI BioPharma Corp.
- National Drug Code (NDC)
- 72482-0100
See also:
Jakafi
Jakafi is used to treat certain types of myelofibrosis or polycythemia vera in adults, and certain ...
Ojjaara
Ojjaara (momelotinib) may be used to treat adults with certain types of myelofibrosis (MF) who have ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Inrebic
Inrebic is used to treat certain types of myelofibrosis (MF) in adults. It is an oral capsule taken ...
Alecensa
Alecensa (alectinib) is an oral kinase inhibitor that may be used to treat certain types of ...
Alunbrig
Alunbrig (brigatinib) is used to treat anaplastic lymphoma kinase-positive (ALK+) metastatic ...
Augtyro
Augtyro (repotrectinib) is a next-generation TKI (Tyrosine Kinase Inhibitor) cancer medicine used ...
Ayvakit
Ayvakit (avapritinib) is a prescription medicine used for the treatment of gastrointestinal stromal ...
Balversa
Balversa (erdafitinib) is an oral kinase inhibitor that may be used to treat adults with locally ...
More about Vonjo (pacritinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.